Medical Xpress: Transcatheter Tricuspid Valve Replacement Aids Tricuspid Regurgitation

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy (OMT) yields substantial improvement in symptoms, function, and quality of life, according to a study published online Oct. 30 in the Journal of the American College of Cardiology. 

Suzanne V. Arnold, MD, from Saint Luke's Mid America Heart Institute/University of Missouri-Kansas City, and colleagues performed an in-depth analysis of the health status of patients enrolled in the TRISCEND II pivotal trial. Patients with symptomatic and severe or greater TR were randomly assigned to TTVR with the EVOQUE tricuspid valve replacement system plus OMT or OMT alone (259 and 133 patients, respectively).

Read the full Medical Xpress article: Transcatheter Tricuspid Valve Replacement Aids Tricuspid Regurgitation

Related Content

Oct. 21, 2024

TCTMD: Slight Uptick in Mortality with TAVI in Recent Years: TVT Registry
Following years of steady improvements in outcomes, more recent observational data suggest that mortality among TAVI patients may be increasing.
May. 2, 2024

American Heart Association: Anger's Role in Heart Attack Risk May Start in the Arteries
Dr. Suzanne Arnold weighs in on new findings that may help explain how anger contributes to the risk of having a heart attack.